Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Applied DNA Sciences, Inc. (APDN) Posts Highest Quarterly Revenues To-Date 1 comment
    Aug 14, 2013 10:57 AM | about stocks: APDN

    Applied DNA Sciences, a provider of DNA-based anti-counterfeiting technology and product authentication solutions, for the third quarter ended June 30, 2013, reported record quarterly revenues attributed to an increase in SigNature DNA-marking contracts.

    Revenues of approximately $645,000 represent the highest quarterly revenues in the company's history, primarily driven by eight new contracts in connection with military electronics effort. In the comparable quarter of the year prior, APDN reported revenue of $528,574.

    APDN management noted that in nearing the milestone of a half-million SigNature DNA-marked electronic components in circulation, the company is in a position to capitalize on the offering of an expanded set of authentication programs in the supply chains impacted.

    "This quarter, APDN signed eight contracts related to Federal Supply Class (NASDAQ:FSC) 5962, doubling the cumulative contracts that had been signed by the previous quarter," Dr. James A. Hayward, president and CEO of APDN, stated in the press release. "We anticipate that this trend will continue, judging from the increasing number of inquiries and companies in various stages of negotiation. Our other product markets continue to contribute to our revenues."

    Net loss for the quarter was $2.1 million as compared to a prior year third-quarter loss of $1.4 million, which the company attributes to an 84.9% increase in selling, general and administrative expenses due to higher professional fees and the relocation of the company's corporate office. APDN's research and development expenses also weighed earnings, up 85.1% to $184,981 as the company conducted additional research and development to expand its patent portfolio.

    For more information, visit adnas.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: APDN
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • meadowlake
    , contributor
    Comments (12) | Send Message
     
    This company is growing sales and revenue.They are facing higher costs for research and growing the company.They have more contracts and growth prospects and have developed a very good product to stop counter-fitting and catch crooks.I think sales and revenue will increase for the next 4 quarters
    20 Dec 2013, 01:27 PM Reply Like
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.